News
A new biotech has come roaring to life in Wales with a $140 million series A and a lead candidate ready for phase 2 trials in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback